Trending Now
Abeona Therapeutics Inc (NASDAQ: ABEO) Recently Issued an Update on Its...
Abeona Therapeutics Inc (NASDAQ: ABEO) recently updated its phase 3 VITAL study to its shareholders and prospective investors. The company announced that it had...
ZyVersa Therapeutics, Inc. (ZVSA): A 38.8% Stock Surge Highlights Innovative Approach...
ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA), a clinical-stage specialty biopharmaceutical company based in Weston, Florida, saw a significant stock boost of 38.8%, closing...
Agrify Corporation (AGFY): Strategic Restructuring and New Leadership Boosts Stock by...
Agrify Corporation (Nasdaq: AGFY), a trailblazer in cannabis cultivation and extraction technology, experienced a significant surge in its stock price, climbing over...
Popular News
Ocugen Inc (NASDAQ:OCGN)’s partner Bharat Biotech rejected by Indian state
Ocugen Inc (NASDAQ:OCGN) is currently trading at $12.05 with a volume of over 52M shares.
Bharat Biotech's home...
MAKE IT MODERN
LATEST REVIEWS
Agrify Corporation (AGFY): Strategic Restructuring and New Leadership Boosts Stock by...
Agrify Corporation (Nasdaq: AGFY), a trailblazer in cannabis cultivation and extraction technology, experienced a significant surge in its stock price, climbing over...
MAKE IT MODERN
PERFORMANCE TRAINING
Atossa Therapeutics Inc (NASDAQ:ATOS) Reports Positive Interim Results From Phase 2 Clinical Trial Of...
Atossa Therapeutics Inc (NASDAQ:ATOS) is excited to announce positive interim results of oral administration of Endoxifen in Phase 2 clinical study in Q4 2020.
The...
Curis Inc. (NASDAQ: CRIS) Doses First Subject in The Combination Therapy Study of CA-4948...
Curis Inc. (NASDAQ: CRIS) has announced the dosing of the first patient in the combination therapy part of the Phase 1/2 clinical trial evaluating...
Germany’s BioNTech SE – ADR (NASDAQ:BNTX) and China’s Shanghai Fosun Pharmaceutical Launch a Clinical...
Coronavirus was first reported in China in Wuhan city. It came with several pneumonia cases. The virus has quickly become a global pandemic claiming...
Fulcrum Therapeutics Inc (NASDAQ: FULC) Recently Issued an Update to Its Shareholders on the...
Fulcrum Therapeutics Inc (NASDAQ: FALC) recently published its findings on its latest study in phase 2. The company's findings highlight that an effective workplace...
Ionis Pharmaceuticals Inc. (NASDAQ:IONS) Announces Q3 2020 Results And Maintains Full-year Financial Guidance
Ionis Pharmaceuticals Inc. (NASDAQ:IONS) has announced its Q3 2020 financial results and business updates indicating that it is on track to attain 2002 financial...
MAKE IT MODERN
POPULAR
